Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Dr Reddy’s Labs rated...

    Dr Reddy’s Labs rated 4th Most Reputed Pharmaceutical Brand: Bluebytes Report

    Written by savita thakur thakur Published On 2016-08-22T12:41:05+05:30  |  Updated On 22 Aug 2016 12:41 PM IST

    Hyderabad : Hyderabad based Dr. Reddy’s Laboratories is India’s 4th Most Reputed Pharmaceutical Brand as per the report by Bluebytes


    . While Aurobindo Pharma occupies 11th position and Natco Pharma stood at 21st place in the pharma list. Suven Life Sciences ranked at 40, Divis Laboratories at 44th, Zenotech Laboratotries at 48th, Indian Immunologicals at 49th and Biological E. ranked 52nd, ruled the roost of pharma brands of India from Hyderabad. 8 Hyderabad based brands made it to India’s Most Reputed Pharmaceutical Brands list. Mumbai based Lupin Pharmaceuticals tops in Reputation in the Pharmaceutical sector leading India’s Most Reputed Pharmaceutical Brands list. Sun Pharma is the second Most Reputed Brand with a 52% lower Brand Rep Score and Cipla is at 3rd position with a Brand Rep Score 28% behind the previous ranked. Among global brands GSK leads the way followed by Pfizer with a Brand Rep Score 73% below the leader among International pharmaceutical companies. Abbott’s Brand Rep Score was 12% lower, ranking it India’s 3rd Most Reputed among International brands. There were 41 Domestic and 17 International pharmaceutical brands listed in the study by BlueBytes conducted in association with TRA Research (both part of the Comniscient Group) which released ‘India’s Most Reputed Pharmaceutical Brands 2016’. This report is the second in the India’s Most Reputed Brands series, and the company is set to launch a report each month covering different sectors. The study evaluates brand’s Brand Reputation by analyzing media perception and consumer perceptions.


    “India’s Reputation as the largest producer of generic drugs in the world has become vulnerable in light of the changing patent regime in the country. Reports say that by 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size. Reputation is defined as a measure of the effectiveness of transmitted belief about attitudes showcasing Respect and our report measures the consumer Respect for a brand and also its transmission by measuring the media quotient. Given the importance of this sector for the economy and to the public, brands should concentrate on building and maintaining their Reputation to stay ahead in the changing world,” said Pooja Kaura, Chief Spokesperson for India’s Most Reputed Brands.


    India’s Most Reputed Pharmaceutical Brands was a study conducted within the Pharmaceutical industry with BlueBytes analyzing news of 58 pharma brands in all the major English and Hindi print media (newspapers and magazines) across 9 cities as a representative of the news across all media. A total of 24,414 articles pharma news were analyzed between July 15, 2015, and July 16, 2016. In addition to news analysis, the consumer’s perception was also studied and this part of the analysis was contributed by TRA Research, which interviewed 2,500 consumer-influencers on the aspect of Respect. The 60-page, soft-bounded report is available for Rs. 999/-.


    ‘India’s Most Reputed Brands’ is a product of BlueBytes in association with TRA Research, both nestled under the Comniscient Group. The companies bring together a unique synergy in the business of Reputation Measurement. The Report leverages their unique specialities BlueBytes, which is focussed on measuring transmission of respect as perceived via the Print Media, and TRA, which specialises in measuring consumer perception. BlueBytes tracks all the brands’ news in all the major English and Hindi print media (newspapers and magazines) across 9 cities as a representative of the news across all publications. While TRA Research contributes with interviews on 2,500 consumer-influencers on the aspect of Commanding Respect. ‘India’s Most Reputed Brands’ is a one-of-a-kind study. BlueBytes and TRA Research are geared towards mapping the Reputation topography of different sectors.

    Aurobindo PharmaBluebytesDr Reddy'sNatco pharmaPfizerPooja KauraSun PharmaSuven Life Sciences
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok